Original ArticleThe Impact of Alternative Treatment for Abnormal Uterine Bleeding on Hysterectomy Rates in a Tertiary Referral Center
Section snippets
Material and Methods
Medical records of all premenopausal patients receiving surgery or LNG-IUD because of abnormal uterine bleeding between January 1, 1995, and December 31, 2004, were reviewed. Abnormal uterine bleeding was defined as menorrhagia, metrorrhagia, or intermenstrual bleeding. Patients were excluded in case of infertility, postmenopausal state, or (suggestion of) malignancy of the genital tract.
Eligible patients were identified based on (specific) diagnostic codes (e.g., for menorrhagia, metrorrhagia,
Results
In the investigated period, 2157 premenopausal patients with AUB attended our clinic. Of this group, 1271 (58.9%) patients received oral medical therapy or no treatment at all; the other 886 (41.1%) patients had either surgical therapy or received LNG-IUD. Within this time frame, staffing remained similar (staffing performing hysterectomy [n = 6] and endoscopic surgery [n = 3]).
Patient characteristics are detailed in Table 1. The mean age at which LNG-IUD (41.6 years) was placed and
Discussion
Even though several alternative treatment modalities were developed to date, the overall hysterectomy rate in the management of AUB did not decrease in our clinic during the years (1995–2004) reviewed in this study. The numbers of hysteroscopic surgeries and insertion of LNG-IUD as alternative treatment for this indication increased. On the contrary, the number of women receiving endometrial ablation declined. A probable explanation for this decline is the replacement by LNG-IUD, introduced in
Conclusion
In our clinic, the hysterectomy rate in the management of AUB did not decrease, despite the introduction of alternative therapies. An explanation to this phenomenon remains speculative, although to assure adequate implementation of alternative therapies it is of great importance to determine, at least nationwide and preferably internationally, its real impact on costs and satisfaction.
References (16)
- et al.
Hysterectomy rates in the United States 1990–1997
Obstet Gynecol
(2002) - et al.
Declining trend in major gynecological surgery in The Netherlands during 1991–1998. Is there an impact on surgical skills and innovative ability?
BJOG
(2001) Prevalence corrected hysterectomy rates and probabilities in Utah
Ann Epidemiol
(2001)Second opinions in laparoscopic cholecystectomy
Lancet
(1994)- et al.
Alternative medical and surgical options to hysterectomy
Best Pract Res Clin Obstet Gynaecol
(2005) - et al.
Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomized trial
Lancet
(2001) - et al.
Hysterectomy and socioeconomic position in Rome
Italy. J Epidemiol Community Health
(2002) - et al.
Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway
N Engl J Med
(1982)
Cited by (20)
Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception
2022, ContraceptionCitation Excerpt :In 2015, this device was approved by the US Food and Drug Administration [5] and in more than 100 countries as a contraceptive method and as a medical treatment for heavy menstrual bleeding. Its use has been associated with a reduction in some medical and surgical treatments, such as use of tranexamic acid, oral progestins, endometrial ablation, and hysterectomy [6-9]. The LNG IUS is recommended as a first-line treatment in women with nonstructural heavy menstrual bleeding [10,11].
Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women
2018, American Journal of Obstetrics and GynecologyCitation Excerpt :This may be due to the increased use of endometrial ablation and progesterone eluting intrauterine devices to control bothersome abnormal bleeding and chronic pelvic pain. These therapies have enabled many premenopausal women to control symptoms without resorting to invasive, extirpative surgery.10 The number of hysterectomies for pelvic organ prolapse also decreased 19.4%.
Temporal trend and nationwide utility for hysterectomies in Taiwan, 1997–2010
2016, Taiwanese Journal of Obstetrics and GynecologyCitation Excerpt :Similar to most surgeries, hysterectomy causes a negative impact on the quality of life. Although a number of less invasive alternative therapies have been developed to replace hysterectomy [9], hysterectomy remains the second most common gynecological surgery in the United States [1]. In this study, we observed that the rate of hysterectomy varied from country to country [3].
Hysterectomy
2013, Women and HealthThe trends of minimally invasive surgery for benign gynecologic lesions, 1997-2007 in Taiwan
2012, Gynecology and Minimally Invasive TherapyCitation Excerpt :Laparoscopy is indicated for benign uterine lesions including uterine myoma and adenomyosis, intractable pelvic pain, severe abnormal uterine bleeding, and poor response to medical treatment. The nonsurgical alternative treatments for benign uterine conditions have been developed to be first-line therapy, including levonorgestrel-releasing intrauterine device, hysteroscopic polyp or myoma removal, and endometrial ablation.13 However, the influence of these procedures on hysterectomy rates currently remains uncertain, due to the lack of long-term research studies that aim to identify the effectiveness of various treatment methods.12
Hysterectomy
2012, Women and Health, Second Edition
The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.